Response to ‘acamprosate better than baclofen for alcohol use disorder in cirrhosis: fact or myth?’

aDepartment of Hepatology, Imperial College Healthcare NHS Trust, St Mary’s Hospital, London, United Kingdom.

bDepartment of Metabolism, Digestion and Reproduction, Section of Hepatology and Gastroenterology, Liver Unit, Imperial College London, St Mary’s Hospital, Praed Street, London, United Kingdom

Received 14 June 2022 Accepted 17 June 2022

Correspondence to Luke David Tyson, MA, MB, BChir, The Liver Unit, 10th floor QEQM building, St Mary’s Hospital, Praed Street, London, W2 1NY, UK., e-mail: [email protected]; ORCID ID: 0000-0003-2745-0282

留言 (0)

沒有登入
gif